Jul 28, 2016
John Audette, Co-Founder and President, Amplion talks about how biomarkers are starting to be used by pharmaceutical and diagnostic companies to create more effective drug treatments and tests that use liquid biopsies for early detection of cancer.
@Amplion
#precisionmedicine
#biomarkers